[ad_1]
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.)
Suan-Sin Foo, University of Southern California and Chen Weiqiang, University of Southern California
(THE CONVERSATION) The sudden and rampant outbreak of Zika virus in 2016 terrified pregnant women, especially those residing in Zika-endemic regions, such as Brazil, Zika virus infection during with a small head, a condition known as microcephaly, and other congenital defects.
The absence of early prenatal diagnosis, or treatment, for mothers-to-be worrying about their baby's well-being. Others, meanwhile, have terminated their pregnancy rather than having a child with birth defects.
Chikungunya virus and Zika virus. Each causes a distinct set of symptoms. Chikungunya virus produces debilitating persistent joint pain in adults and neurological symptoms in children; Zika virus causes defects in babies. In Jae Jung's lab at the University of Southern California, we are investigating the mechanisms that underlie the devastating consequences of these viral infections and developing new prenatal diagnosis.
Zika and pregnancy
Zika is the first mosquito-terminal known to cause congenital defects. Aedes aegypti, one of the most invasive and widespread species of mosquito, is the primary vector for transmitting Zika. When healthy individuals, who are not pregnant, are infected with Zika virus infection often because they are mild or negligible. However, infection during the first and second trimester of pregnancy, the risk of miscarriages and various fetal defects such as eye abnormalities, neurological impairment and more severe cases, microcephaly.
Health workers try to assess the health of Zika using ultrasound during the second trimester or later. But it is difficult to see these images if the baby has developmental abnormalities.
On the other hand, fetal MRI captures high-resolution snapshots of the fetus. But this imaging technique can only be used in the second or third trimesters – when it is more difficult to terminate a pregnancy. A diagnostic assay that could detect abnormalities early in the pregnancy could alleviate the mother's stress and make it easier to make swift reproductive decisions.
Developing a new diagnostic test
During the Zika outbreak in Brazil, there were other co-circulating mosquito-terminal viruses such as Dengue virus and Chikungunya virus. So we are here to take blood samples from women of the US where these viruses are not endemic. In our recent research, we surveyed blood samples from 74 pregnant women: 30 were Zika-positive, 30 were negative and 14 were from women in Los Angeles. This study was led by Jae Jung, in collaboration with Patrícia Brasil of the National Institute of Infectology Evandro Chagas in Brazil, and Karin Nielsen-Saines and Genhong Cheng of UCLA.
Our findings revealed an elevated production of 16 specific biomarkers, which are present in the blood of pregnant women. These biomarkers are potentially useful for predicting the outcomes of Zika pregnancies simply using blood specimens from the mother-to-be at any stage of pregnancy.
The number of Zika cases has dramatically declined following the major outbreaks in 2016. Yet, many Zika babies are still suffering from the dire consequences of prenatal infection. With the widespread abundance of Aedes mosquitoes, and the fact that Zika virus has not been eradicated, new outbreaks of Zika can occur anytime.
We are continuing our research to understand how Zika disrupts the development of the fetus, treatment strategies for babies affected by the virus, and ways to prevent Zika infection in the first place. Only when we have a thorough understanding of Zika infections can we assure the health of future generations.
This article is republished from the Creative Commons license. Read the original article here: http://theconversation.com/prenatal-blood-screening-may-predict-zika-virus-associated-fetal-defects-106133.
Source link
